- Home
- LBTYA vs ASND Comparison
LBTYA vs ASND Comparison
Compare LBTYA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBTYA | ASND |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | Bermuda | Denmark |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 12.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | LBTYA | ASND |
|---|---|---|
| Price | $11.18 | $198.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 15 |
| Target Price | $14.77 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 2.0M | 794.8K |
| Earning Date | 10-30-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,770,600,000.00 | $758,592,045.00 |
| Revenue This Year | $13.22 | $99.74 |
| Revenue Next Year | $1.67 | $79.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 170.50 | 97.46 |
| 52 Week Low | $9.03 | $118.03 |
| 52 Week High | $13.17 | $229.94 |
Technical Indicators
Market Signals| Indicator | LBTYA | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 45.49 |
| Support Level | $10.87 | $192.28 |
| Resistance Level | $11.37 | $213.22 |
| Average True Range (ATR) | 0.30 | 10.39 |
| MACD | -0.02 | -0.84 |
| Stochastic Oscillator | 51.08 | 22.68 |
Price Performance
Historical ComparisonAbout LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.